June 9, 2023 — Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for ...
June 9, 2023 — Dasi Simulations announced it received FDA clearance for its artificial intelligence model for ...
June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 9, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...
June 9, 2023 — Google Cloud announced a collaboration with Mayo Clinic to transform healthcare with generative AI ...
June 8, 2023 — The Society for Vascular Medicine (SVM) is gearing up with a full program schedule as the June 23 Early ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...
June 7, 2023 — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, announced that the U.S ...
June 7, 2023 — Praveena Paruchuri, MD, is a cardiology specialist with 17 years of experience. She comes to Auburn ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 7, 2023 — The U.S. Food and Drug Administration (FDA) has announced the availability of a draft guidance with ...
June 7, 2023 — Magenta Medical Ltd. has announced the initiation of its FDA-approved Early Feasibility Study with the ...
June 6, 2023 — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the U ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 6, 2023 — According to a news release issued by the U.S. Food and Drug Administration (FDA), Abiomed has recalled ...
June 5, 2023 — The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic ...
June 5, 2023 — Lexicon Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...